Fundraising Fox

Tenpoint Therapeutics

Warren, US · Founded 2019 · 132 employees on LinkedIn · 3 known investors

Find your way into Tenpoint Therapeutics

Tenpoint Therapeutics develops treatments for age-related ophthalmic conditions, with an initial focus on presbyopia care for the aging eye. The company works with eye care professionals to advance therapies in the ophthalmology market.

BiotechDigital HealthHealthtechLongevityMedical Devices

Founders & leadership

HBHENRIC BJARKE
HENRIC BJARKEinChief Executive Officer

Investors · 3

AdBio partnersParis
F-Prime CapitalCambridge · $3M – $10M
Sofinnova PartnersParis · $540K – $27M

Funding

SEC filings, press & company announcements

$235M disclosed across 1 of 3 rounds · 2026

Source: company announcements and press reports — follow each round's link for the claim.

Competitors · 2

by search overlap
Myeyedr52 shared keywordsMyEyeDr. is an optometry practice network providing vision care services across the United States. The company prioritizes community engagement through volunteer eye care services, medical missions, and partnerships with local organizations.
Ocumetra46 shared keywordsOcumetra develops data science and business intelligence tools focused on myopia management and eye health for eye care professionals, including optometrists and ophthalmologists. The company creates clinical analytics platforms to help improve patient outcomes in childhood myopia management.

Companies competing with Tenpoint Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.

In the news

Tenpoint Therapeutics launches with $70 million in funding for cell therapy platform | Eye Care Network - Ophthalmology Times Europeophthalmologytimes.com · Aug 2026Tenpoint Therapeutics and Visus Therapeutics complete merger, combining ophthalmic therapeutics portfolios | Eye Care Network - Ophthalmology Timesophthalmologytimes.com · Aug 2026Fierce Biotech Fundraising Tracker '26: InduPro assembles $77M; Vaderis nets $152M series Bfiercebiotech.com · Aug 2026Tenpoint Therapeutics raises $70M Series A to restore vision — Sofinnova Partnerssofinnovapartners.com · Jun 2026Company News & Press | Tenpoint Therapeutics™tenpointtherapeutics.com · Apr 2026Tenpoint Therapeutics Secures $235 Million through Series B Stock Financing and Credit Facility to Accelerate Commercialization of YUVEZZI™ - BioSpacebiospace.com · Jan 2026Tenpoint Therapeutics Secures $235 Million through Series B Stock Financing and Credit Facility to Accelerate Commercialization of YUVEZZI™finance.yahoo.com · Jan 2026Tenpoint Therapeutics Raises $235M Through Series B and Credit Facilityfinsmes.com · Jan 2026

Frequently asked questions

What does Tenpoint Therapeutics do?
Tenpoint Therapeutics develops treatments for age-related ophthalmic conditions, with an initial focus on presbyopia care for the aging eye. The company works with eye care professionals to advance therapies in the ophthalmology market.
Who are Tenpoint Therapeutics's investors?
Tenpoint Therapeutics's investors include AdBio partners, F-Prime Capital, Sofinnova Partners.
How much funding has Tenpoint Therapeutics raised?
Tenpoint Therapeutics has disclosed $235M raised across 1 of its 3 known rounds.
Where is Tenpoint Therapeutics headquartered?
Tenpoint Therapeutics is headquartered in Warren, US.